Year
2026
Organisation
Summary
This research develops a systemic therapy for spinal muscular atrophy by combining genetic correction with improved delivery. A DNA-like molecule restores proper protein production, while a carrier enables distribution throughout the body. This approach aims to overcome limitations of current treatments and enable whole-body therapeutic effects.